Related Experiment Video
Updated: Jul 12, 2025

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells
Published on: November 2, 2017
E3 ligase SOCS3 regulates NOD2 expression by ubiquitin proteasome system in lung cancer progression
In-Ho Jeong1, Jae Kwang Yun2, Jun-O Jin3
1Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, Korea.
Purpose:
Despite lung cancer is one of the leading causes of cancer-related deaths, it remains hard to discover effective diagnostic and therapeutic approaches. Moreover, the five-year survival rate is relatively lower than other tumors. So urgent needs for finding a new theranostic target to treat lung cancer effectively. This study aims to present SOCS3 and NOD2 proteins as novel targets for diagnosis and therapy.
Methods:
We first confirmed SOCS3 expression level in patients' tissues. Then, we applied knockdown and overexpression of SOCS3 on lung cancer cell lines and performed proliferation, migration, and invasion assay. After that, we found NOD2 is a target of SOCS3 and introduced overexpression of NOD2 to A549 for verifying reduced tumorigenicity of lung cancer cells.
Results:
We identified protein expression level of SOCS3 was frequently higher in tumor tissues than adjacent normal tissues. Truly, overexpression of SOCS3 promoted proliferation, migration, and invasion capacity of lung cancer cells. We found that SOCS3 interacts with NOD2 and SOCS3 ubiquitinates NOD2 directly. Furthermore, lung cancer tissues with higher SOCS3 expression showed lower NOD2 expression. We confirmed overexpression of NOD2 leads to suppressed tumorigenicity of lung cancer cells, and these effects occurred through MAPK pathway.
Conclusion:
Collectively, our work reveals novel roles of SOCS3 in lung tumorigenesis and proposes SOCS3 as a promising biomarker candidate for therapeutic and diagnostic target for lung cancer.
Insights
This study identifies Suppressor of Cytokine Signaling 3 (SOCS3) as a key driver in lung cancer progression. Targeting SOCS3 and its interaction with Nucleotide-binding Oligomerization Domain 2 (NOD2) offers a promising new strategy for lung cancer diagnosis and therapy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Lung cancer remains a leading cause of cancer mortality with limited effective treatments.
- There is an urgent need for novel diagnostic and therapeutic targets to improve patient outcomes.
Purpose of the Study:
- To investigate the roles of Suppressor of Cytokine Signaling 3 (SOCS3) and Nucleotide-binding Oligomerization Domain 2 (NOD2) in lung cancer.
- To explore SOCS3 and NOD2 as potential theranostic targets for lung cancer.
Main Methods:
- Assessed SOCS3 expression in lung cancer tissues.
- Utilized gene knockdown and overexpression in lung cancer cell lines to evaluate proliferation, migration, and invasion.
- Investigated the interaction between SOCS3 and NOD2, including ubiquitination.
- Examined the effect of NOD2 overexpression on lung cancer cell tumorigenicity via the MAPK pathway.
Main Results:
- SOCS3 expression was elevated in lung tumor tissues compared to normal tissues.
- Overexpression of SOCS3 enhanced lung cancer cell proliferation, migration, and invasion.
- SOCS3 directly ubiquitinates NOD2, and higher SOCS3 levels correlated with lower NOD2 expression in tumors.
- Overexpression of NOD2 suppressed lung cancer cell tumorigenicity, mediated by the MAPK pathway.
Conclusions:
- SOCS3 plays a significant role in lung tumorigenesis.
- SOCS3 and NOD2 represent novel therapeutic and diagnostic targets for lung cancer.
- This research highlights potential new avenues for lung cancer treatment and diagnosis.
Related Concept Videos
Regulation of Nuclear Protein Sorting
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Regulation of Expression at Multiple Steps
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Abnormal Proliferation

